Skip to content

Long-term effect of Huosu Yangwei oral Liquid on atrophic gastritis based on histopathological changes

Long-term effect of Huosu Yangwei oral Liquid on atrophic gastritis based on histopathological changes

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17010685
Enrollment
Unknown
Registered
2017-02-20
Start date
2018-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic atrophic gastritis

Interventions

four:HuoSu nourishing the stomach oral liquid

Sponsors

Yueyang Affiliated to Shanghai University of Traditional Chinese Medicine, Integrated Chinese and Western Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) in accordance with the above criteria for the diagnosis of western medicine to chronic atrophic gastritis; (2) into the group on electronic gastroscope and histologic diagnosis of atrophic inherent glands (decrease) with or without light, moderate intestinal (intestinal metaplasia), with or without light, moderate hyperplasia; (3) Male and female aged between 20 to 65 years old; (4) subjects were informed, voluntary signed informed consent; (5) the permanent local, can guarantee the follow-up treatment, has the certain reading ability; (6) did not take aspirin and warfarin anticoagulant drugs and coagulation function disorder.

Exclusion criteria

Exclusion criteria: (1) the autoimmune gastritis of chronic atrophic gastritis (type A); (2) with gastric and duodenal ulcer, upper gastrointestinal bleeding; (3) there are high levels in gastric mucosa intraepithelial neoplasia or pathological diagnosis of suspected malignant change; (4) the combination of heart, brain, liver, kidney, lung, and blood system and so on serious primary diseases; (5) psychiatric patients; (6) pregnancy or lactation women (female participants must take contraception); (7) allergic constitution or for a variety of drugs (two or more known in the study drug or composition) has a history of allergies; (8) the researchers think not appropriate to be included in the other condition; (9) is in clinical trials of patients with other drugs.

Design outcomes

Primary

MeasureTime frame
The pathologic result;Mucosal lesions under gastroscope;TCM symptoms curative effect;

Countries

China

Contacts

Public ContactXIiaosu Wang

Yueyang Affiliated to Shanghai University of Traditional Chinese Medicine, Integrated Chinese and Western Medicine Hospital

xswangxs0084@163.com+86 18930565281

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026